CRONOS GROUP INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CRONOS GROUP INC. (CRON) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-26
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 0.00 shares.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 0.00 shares.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 0.00 shares.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 188.32K shares.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 188.32K shares, a 65.27% increase from fiscal 2022.
- CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 113.95K shares, a 87.34% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-26 | |||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-27 | 188.32K shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 188.32K shares 10-Q · filed 2024-11-12 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 188.32K shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 188.32K shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 113.95K shares 10-K · filed 2024-02-29 | |||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 900.00K shares derived: sum of 2 quarters · filed 2023-02-28 | 900.00K shares 10-K · filed 2023-02-28 | |
| 2021-09-30 | 900.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-07 | 900.00K shares 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | 0.00 shares 10-Q/A · filed 2022-02-18 | |||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 2.00M shares derived: sum of 2 quarters · filed 2022-03-01 | 2.00M shares 10-K · filed 2022-03-01 | |
| 2020-09-30 | 2.00M shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | 2.00M shares 10-Q · filed 2022-02-18 | ||
| 2020-06-30 | 0.00 shares 10-Q/A · filed 2022-02-18 | |||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | 218.38K shares derived: sum of 2 quarters · filed 2021-02-26 | 1.48M shares derived: sum of 3 quarters · filed 2021-02-26 | 1.53M shares 10-K · filed 2021-02-26 |
| 2019-09-30 | 218.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 1.48M shares derived: sum of 2 quarters · filed 2020-11-05 | 1.53M shares 10-Q · filed 2020-11-05 | |
| 2019-06-30 | 1.26M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 1.32M shares 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 51.83K shares 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | 1.91M shares 10-K/A · filed 2020-03-30 | |||
| 2017-12-31 | 6.40M shares 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |